Science to Practice: Systemic Implications of Ablative Tumor Therapies—Reality Uncovered and Myths Exposed?
Chapiro J, Geschwind JF. Science to Practice: Systemic Implications of Ablative Tumor Therapies—Reality Uncovered and Myths Exposed? Radiology 2016, 280: 329-331. PMID: 27429140, DOI: 10.1148/radiol.2016160505.Peer-Reviewed Original ResearchIrreversible Electroporation in Interventional Oncology: Where We Stand and Where We Go
Savic LJ, Chapiro J, Hamm B, Gebauer B, Collettini F. Irreversible Electroporation in Interventional Oncology: Where We Stand and Where We Go. RöFo 2016, 188: 735-745. PMID: 27074423, DOI: 10.1055/s-0042-104203.Peer-Reviewed Original ResearchConceptsClinical evidenceIrreversible electroporationInterventional oncologyPancreatic irreversible electroporationSite-specific complicationsAvailable clinical evidenceUse of IRELimited clinical evidenceFavorable safety profileTolerable morbidityOncologic efficacyPreclinical findingsBile ductSafety profileNeurovascular bundleInvasive treatmentLung parenchymaAblation therapySolid tumorsClinical settingTumor ablation therapyHeat sink effectNon-thermal fashionLiverTumor ablation